PepDiana
Back to Evidence
Primary experimental recordPositive observation

PMC11431785::ACT007063

P4

Evidence text

Paper-level observation

Section 2.4: 'For Ctn[15-34] re ... at LPS/peptide ratios of 0.1:0.1, TNF-α levels evidencing high inflammation ... were found.'
textConfidence: medium

Assay observation

Activity
Immunomodulatory
Subtype
Not reported by source
Measure
other
Comparator
=
Raw observation
high inflammation at LPS/peptide 0.1:0.1
Normalized measurement
=0.1
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
human MNC
Assay method
Not reported by source
Sequence
FPITVGIVMPKKFIKKLRKK
Standardization
ready simple

Source publication

From In Vitro Promise to In Vivo Reality: An Instructive Account of Infection Model Evaluation of Antimicrobial Peptides.

International Journal of Molecular Sciences · 2024

DOI 10.3390/ijms25189773 PMC11431785
Parent mention

Related peptide identities

PEPDIA-PLP-000777

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.